Kumthekar PU, Avram MJ, Lassman AB, Lin NU, et al. A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro Oncol 2023;25:557-565.
PMID: 35948282